CAPRICOR THERAPEUTICS, INC. (CAPR) Operating income 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual operating income history from SEC filings — each fiscal year as reported.
-$108.1MFY2025 · since FY2016: -$17.0M → -$108.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$108.1M | -154.1% |
| FY2024 | -$42.6M | -76.8% |
| FY2023 | -$24.1M | +18.9% |
| FY2022 | -$29.7M | -41.8% |
| FY2021 | -$20.9M | -52.9% |
| FY2020 | -$13.7M | -77.0% |
| FY2019 | -$7.7M | +49.5% |
| FY2018 | -$15.3M | -19.2% |
| FY2017 | -$12.9M | +24.2% |
| FY2016 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating marginCAPR Operating cash flowCAPR Free cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →